Please assess the completion status of the following clinical trial:

Trial Title: Double-Blinded Clinical Trial Using Apatone®B for Symptomatic Postoperative Total Joint Replacements

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Postoperative Total joint replacement with osteoarthritis as the underlying pathology~* Proven non-infected symptomatic Total Joint Arthroplasty (TJA) (joint implanted for \>12 months post-op)~* Age (50 to 85 years of age); based on a 10% trim of the age distribution for Summa Health System TJAs (7/1/08-6/30/2009).~Exclusion Criteria:~* An infection of any kind (prior to, or during the study)~* Rheumatoid arthritis as the underlying pathology~* Cortisone injection received \<6 months prior to study enrollment~* Insulin dependent diabetes~* Diagnosed immunodeficiency~* On dialysis or have poor kidney function~* Anti-coagulant medication (e.g., Coumadin or \>100mg of Aspirin daily)~* Anti-seizure medication (e.g., Dilantin)~* Steroidal medication (e.g., Prednisone, Advair or Symbicort)~* NSAIDS (e.g., Celebrex or Toradol); a 14-day washout period will be allowed~* bisphosphonates (e.g., Fosamax, Actonel, Aredia, Didronel, Boniva or Reclast)~* hormonal therapy (e.g., Estrogen, Progesterone or Testosterone)~* Cancer (active or in remission)~* Planned concurrent vitamins exceeding a standard daily multivitamin or exceeding the Recommended Daily Allowance (RDA) for individual vitamins if used alone; a 72 hour wash out period will be allowed~* A glucose-6-phosphate dehydrogenase (G6PD) deficiency~* Pregnant or lactating; females who are in their reproductive years must have a negative serum pregnancy~* Lactose intolerant~* Citric acid intolerant

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: 85 Years
- Healthy Volunteers: t

Study Arms:
- oral Apatone®B (Type: EXPERIMENTAL): An amalgam of Vitamins C \& K3
- Placebo (Type: PLACEBO_COMPARATOR): Oral capsule of similar appearance and taste without Apatone®B

Based on this trial design, predict the completion outcome and termination type (if applicable).